Title | Description |
|---|---|
| Trial ID | KF5503/16 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine |
| Indication | Chronic Pain, malignant tumor-related pain |
| UTN | |
| CTG ID | NCT00505414 |
| CTIS ID (former EudraCT) | 2007-001985-34 |
| Trial status | Terminated |
| FPI | June 29, 2007 |
| LPO | February 2, 2009 |
| Countries | Argentina, Chile, France, Latvia, Ukraine, United States |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.